4//SEC Filing
Rubin Eyal 4
Accession 0001415889-24-023907
CIK 0001006281other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:00 PM ET
Size
5.4 KB
Accession
0001415889-24-023907
Insider Transaction Report
Form 4
Rubin Eyal
Sr. VP & CFO
Transactions
- Award
Common Stock
2024-09-23+99,010→ 669,010 total(indirect: By Trust)
Footnotes (2)
- [F1]Represents fully-vested restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001721411
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:00 PM ET
- Size
- 5.4 KB